Association between first injection risk behaviors and hepatitis C seropositivity among injecting drug users

Annales de Medecine Interne

Volumn 153, Issue 4, 2002, Pages 219-225

  Vidal Trecan, Gwenaëlle M ^a   Varescon Pousson, Isabelle ^a   Gagnière, Bertrand ^a   Tcherny Lessenot, Stéphanie ^a   Madariaga, Eléonore ^a   Boissonnas, Alain ^a  

^a Université René Descartes ^*  (France)

Author keywords

Hepatitis C like viruses; Injecting behaviors; Intravenous; Substance abuse

Indexed keywords

ILLICIT DRUG;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; FRANCE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRISON; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; SERODIAGNOSIS;

ADULT; FEMALE; HEPATITIS C; HUMANS; MALE; NEEDLE SHARING; ODDS RATIO; RISK-TAKING; SEROLOGIC TESTS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0036342403     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Correlates of hepatitis C virus infections among injection drug users
2. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
3. Hepatitis C virus transmission dynamics in injection drug users
4. Methods of transmission of hepatitis C
5. Hepatitis C virus in intravenous drug users
6. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users
7. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses
8. Seroepidemiology of viral infections among intravenous drug users in Northern California
9. Extent and nature of transitions of route among heroin addicts in treatment-preliminary data from the Drug Transitions Study
10. Initiation into intravenous drug abuse
11. Prise de risques lors de la première injection intraveineuse de drogue
12. Age at first injection and HIV risk among intravenous drug users
13. Les attitudes et les pratiques des usagers de drogues confrontés aux risques de contamination par le virus de l'immunodéficience humaine (VIH) et les virus des hépatites B et C
14. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study
15. Patterns of sexual and injecting risk behaviours in French intravenous drug users not reporting HIV and hepatitis C virus seropositivities
16. Hepatitis C virus infection in Italian intravenous drug users: Epidemiological and clinical aspects
17. Hepatitis C virus infection in intravenous drug users: Prevalence and risk factors
18. Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus type 1 testing program
19. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy
20. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam
21. Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark
22. Syringe-mediated drug sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathogens
23. Syringe-mediated drug-sharing (backloading): A new risk factor for HIV among injecting drug users
24. Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin
25. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: A preliminary laboratory report
26. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland
27. Measuring injecting risk behaviour in the second decade of harm reduction: A survey of injecting drug users in England
28. A short questionnaire (IRQ) to assess injecting risk behaviour
29. Sharing of drug preparation equipment as a risk factor for hepatitis C
30. Prevalence of hepatitis C among injection drug users in England and Wales: Is harm reduction working?
31. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study
32. The protective effect of AIDS-related behavioral change among injection drug users: A cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use
33. Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs
34. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study
35. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs
36. Syringe and needle exchange as HIV/AIDS prevention for injection drug users
37. Syringe exchange and risk of infection with hepatitis B and C viruses
38. Syringe vending machines for injection drug users: An experiment in Marseille, France
39. Et les correspondants des CSSTH infections à VIH et VHC et mortalité chez les résidents des centres de soins spécialisés pour toxicomanes avec hébergement
40. Detection of antibodies against hepatitis C virus in saliva: A marker of viral replication
41. Correlates of human immunodeficiency virus infection in intravenous drug users: Are treatment-program samples misleading?
42. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995
43. Self-report among injecting drug users: A review
44. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users
45. The consistency of self-reported HIV risk behavior among injection drug users
46. HCV status knowledge and risk behaviours amongst intravenous drug users